Ensuring the safety of new medications and devices: are naltrexone implants safe? (editorial)

- Wodak, Alex D., Ali, Robert, Henry, David, Sansom, Lloyd

Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)

- McKetin, Rebecca, Najman, Jake M., Baker, Amanda L., Lubman, Dan I., Dawe, Sharon, Ali, Robert, Lee, Nicole K., Mattick, Richard P., Mamun, Abdullah

Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users

- McKetin, Rebecca, Gardner, Jonathan, Baker, Amanda L., Dawe, Sharon, Ali, Robert, Voce, Alexandra, Leach, Liana S., Lubman, Dan I.

Latent psychotic symptom profiles amongst people who use methamphetamine: what do they tell us about existing diagnostic categories?

- McKetin, Rebecca, Voce, Alexandra, Burns, Richard, Ali, Robert, Lubman, Dan I., Baker, Amanda L., Castle, David J.

The contribution of methamphetamine use to crime: evidence from Australian longitudinal data

- McKetin, Rebecca, Boden, Joseph M., Foulds, James A., Najman, Jake M., Ali, Robert, Degenhardt, Louisa, Baker, Amanda L., Ross, Joanne, Farrell, Michael, Weatherburn, Don

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

- Farrell, Michael, Shahbazi, Jeyran, Byrne, Marianne, Grebely, Jason, Lintzeris, Nicholas, Chambers, Mark, Larance, Briony, Ali, Robert, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Nicholas, Thomas, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa